Native LDL-induced oxidative stress in human proximal tubular cells: multiple players involved

Dyslipidemia is a well‐established condition proved to accelerate the progression of chronic kidney disease leading to tubulo‐interstitial injury. However, the molecular aspects of the dyslipidemia‐induced renal damage have not been fully clarified and in particular the role played by low‐density lipoproteins (LDLs). This study aimed to examine the effects of native non‐oxidized LDL on cellular oxidative metabolism in cultured human proximal tubular cells. By means of confocal microscopy imaging combined to respirometric and enzymatic assays it is shown that purified native LDL caused a marked increase of cellular reactive oxygen species (ROS) production, which was mediated by activation of NADPH oxidase(s) and by mitochondrial dysfunction by means of a ROS‐induced ROS release mechanism. The LDL‐dependent mitochondrial alterations comprised inhibition of the respiratory chain activity, enhanced ROS production, uncoupling of the oxidative phosphorylation efficiency, collapse of the mtΔΨ, increased Ca2+ uptake and loss of cytochrome c. All the above LDL‐induced effects were completely abrogated by chelating extracellular Ca2+ as well as by inhibition of the Ca2+‐activated cytoplas‐mic phospholipase A2, NADPH oxidase and mitochondrial permeability transition. We propose a mechanicistic model whereby the LDL‐induced intracellular redox unbalance is triggered by a Ca2+ inward flux‐dependent commencement of cPLA2 followed by activation of a lipid‐ and ROS‐based cross‐talking signalling pathway. This involves first oxidants production via the plasmamembrane NADPH oxidase and then propagates downstream to mitochondria eliciting redox‐ and Ca2+‐dependent dysfunctions leading to cell‐harming conditions. These findings may help to clarify the mechanism of dyslipidemia‐induced renal damage and suggest new potential targets for specific therapeutic strategies to prevent oxidative stress implicated in kidney diseases.

[1]  João Wosniak,et al.  Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. , 2008, Antioxidants & redox signaling.

[2]  J. Sowers,et al.  Redox control of renal function and hypertension. , 2008, Antioxidants & redox signaling.

[3]  Y. Ho,et al.  Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. , 2008, Free radical biology & medicine.

[4]  L. Fried Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. , 2008, Kidney international.

[5]  Hyun Soon Lee,et al.  Oxidized Low-Density Lipoprotein and Oxidative Stress in the Development of Glomerulosclerosis , 2008, American Journal of Nephrology.

[6]  M. Mattson,et al.  Superoxide Flashes in Single Mitochondria , 2008, Cell.

[7]  P. Pinton,et al.  The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. , 2008, Biochimica et biophysica acta.

[8]  H. Sumimoto Structure, regulation and evolution of Nox‐family NADPH oxidases that produce reactive oxygen species , 2008, The FEBS journal.

[9]  Michael S Janes,et al.  The selective detection of mitochondrial superoxide by live cell imaging , 2008, Nature Protocols.

[10]  C. Winterbourn,et al.  Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.

[11]  A. Fogo Mechanisms of progression of chronic kidney disease , 2007, Pediatric Nephrology.

[12]  A. Fisher,et al.  Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. , 2007, Molecular biology of the cell.

[13]  H. Ginsberg,et al.  Lipoprotein metabolism in chronic renal insufficiency , 2007, Pediatric Nephrology.

[14]  M. Runge,et al.  Mitochondrial Dysfunction in Atherosclerosis , 2007, Circulation research.

[15]  K. Homma,et al.  Ca2+ channel subtypes and pharmacology in the kidney. , 2007, Circulation research.

[16]  KoichiroHomma,et al.  Ca2+ Channel Subtypes and Pharmacology in the Kidney , 2007 .

[17]  Yi-Jun Wu,et al.  Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells. , 2007, Life sciences.

[18]  C. Chinopoulos,et al.  Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.

[19]  R. Levy The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. , 2006, Biochimica et biophysica acta.

[20]  C. Wilcox,et al.  NADPH oxidases in the kidney. , 2006, Antioxidants & redox signaling.

[21]  H. Westerhoff,et al.  A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. , 2006, Antioxidants & redox signaling.

[22]  Mason W Freeman,et al.  Scavenger receptors in atherosclerosis: beyond lipid uptake. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Douglas,et al.  Oxidative signaling in renal epithelium: Critical role of cytosolic phospholipase A2 and p38(SAPK). , 2006, Free radical biology & medicine.

[24]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[25]  T. Kodama,et al.  Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. , 2006, The American journal of pathology.

[26]  S. Sollott,et al.  Mitochondrial ROS-induced ROS release: an update and review. , 2006, Biochimica et biophysica acta.

[27]  I. Fearon OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production. , 2006, Cardiovascular research.

[28]  M. Lorusso,et al.  Arachidonic acid induces specific membrane permeability increase in heart mitochondria , 2006, FEBS letters.

[29]  A. Cases,et al.  Dyslipidemia and the progression of renal disease in chronic renal failure patients. , 2005, Kidney international. Supplement.

[30]  D. Wallace A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[31]  P. Waring,et al.  Redox active calcium ion channels and cell death. , 2005, Archives of biochemistry and biophysics.

[32]  E. N. Wardle Cellular Oxidative Processes in Relation to Renal Disease , 2005, American Journal of Nephrology.

[33]  Tetsuhiro Tanaka,et al.  Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. , 2004, Journal of the American Society of Nephrology : JASN.

[34]  Takao Shimizu,et al.  Regulatory mechanism and physiological role of cytosolic phospholipase A2. , 2004, Biological & pharmaceutical bulletin.

[35]  M. Prato,et al.  Arachidonic Acid Released by Phospholipase A2 Activation Triggers Ca2+-dependent Apoptosis through the Mitochondrial Pathway* , 2004, Journal of Biological Chemistry.

[36]  P. Fauré,et al.  Cell culture media are potent antioxidants that interfere during LDL oxidation experiments. , 2004, Biochimie.

[37]  M. Kretzler,et al.  Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. , 2004, The American journal of pathology.

[38]  R. Zager,et al.  Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade. , 2003, American journal of physiology. Renal physiology.

[39]  R. Levy,et al.  The requirement of cytosolic phospholipase A2 for the PMA activation of proton efflux through the N-terminal 230-amino-acid fragment of gp91phox. , 2003, The Biochemical journal.

[40]  R. Zager,et al.  Acute tubular injury causes dysregulation of cellular cholesterol transport proteins. , 2003, The American journal of pathology.

[41]  T. Finkel Oxidant signals and oxidative stress. , 2003, Current opinion in cell biology.

[42]  A A Gerencsér AA,et al.  Selective, high-resolution fluorescence imaging of mitochondrial Ca2+ concentration. , 2001, Cell calcium.

[43]  D. Harris,et al.  Tubular‐interstitial interactions in proteinuric renal diseases , 2001 .

[44]  A. Rittenhouse,et al.  Arachidonic acid both inhibits and enhances whole cell calcium currents in rat sympathetic neurons. , 2001, American journal of physiology. Cell physiology.

[45]  A E Vercesi,et al.  Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.

[46]  Steven J. Sollott,et al.  Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.

[47]  L. Blatter,et al.  Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. , 1999, The Biochemical journal.

[48]  S. Papa,et al.  Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. , 1999, Free radical biology & medicine.

[49]  M. Trush,et al.  Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. , 1998, Biochemical and biophysical research communications.

[50]  S. Lenzen,et al.  Relation between accumulation of phospholipase A2 reaction products and Ca2+ release in isolated liver mitochondria. , 1996, Biochimica et biophysica acta.

[51]  J. Gaillard,et al.  Electron transfer across the O2- generating flavocytochrome b of neutrophils. Evidence for a transition from a low-spin state to a high-spin state of the heme iron component. , 1996, Biochemistry.

[52]  G. Brown,et al.  Control of respiration and ATP synthesis in mammalian mitochondria and cells. , 1992, The Biochemical journal.

[53]  R. P. Noble Electrophoretic separation of plasma lipoproteins in agarose gel. , 1968, Journal of lipid research.

[54]  Chao-Yung Wang,et al.  Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. , 2008, Trends in molecular medicine.

[55]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[56]  S. Sasaki,et al.  Function of chloride channels in the kidney. , 2005, Annual review of physiology.

[57]  J. Dordick,et al.  Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. , 2002, Endothelium : journal of endothelial cell research.

[58]  D. Lichtenberg,et al.  Continuous monitoring of intermediates and final products of oxidation of low density lipoprotein by means of UV-spectroscopy. , 1996, Free radical research.

[59]  J. Berliner,et al.  The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.

[60]  T. Carew,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[61]  B. Chance,et al.  Reactive oxygen intermediates in biochemistry. , 1986, Annual review of biochemistry.

[62]  W. Kannel,et al.  Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. , 1981, Progress in lipid research.